BioOne bioone.jp


BioOne offers the Intercept Blood System, a system to inactivate pathogens and lymphocytes in blood products. The technology was developed by Cerus Corporation

BioOne offers the Intercept Blood System, a system to inactivate pathogens and lymphocytes in blood products. The technology was developed by Cerus Corporation

Company (Alive / Active)

All investors data 1 Investors

Phone:

Fax:

Daiichikangin-Inagaki Building 8F,
2-1, Shimomiyabi-cho
 162-0822
 Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioOne $0M Oct 26, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioOne Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)